Archivio istituzionale della ricerca dell'Università degli Studi di Palermo

BAZAN, Viviana
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.998
EU - Europa 13.323
AS - Asia 10.268
SA - Sud America 1.581
AF - Africa 301
OC - Oceania 53
Continente sconosciuto - Info sul continente non disponibili 14
Totale 48.538
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 22.646
SG - Singapore 3.909
RU - Federazione Russa 3.377
CN - Cina 2.633
IT - Italia 2.391
DE - Germania 1.896
FI - Finlandia 1.799
BR - Brasile 1.283
HK - Hong Kong 1.031
VN - Vietnam 897
UA - Ucraina 732
GB - Regno Unito 639
PL - Polonia 585
FR - Francia 481
IE - Irlanda 389
JP - Giappone 368
SE - Svezia 321
IN - India 261
KR - Corea 243
CA - Canada 171
NL - Olanda 146
BD - Bangladesh 138
IQ - Iraq 125
BE - Belgio 124
TR - Turchia 123
RO - Romania 111
MX - Messico 105
AR - Argentina 101
AT - Austria 90
ZA - Sudafrica 69
ES - Italia 67
IR - Iran 66
PK - Pakistan 62
AU - Australia 48
CI - Costa d'Avorio 48
ID - Indonesia 45
MA - Marocco 45
EC - Ecuador 40
VE - Venezuela 40
UZ - Uzbekistan 39
MY - Malesia 36
PH - Filippine 35
TN - Tunisia 29
CL - Cile 28
CZ - Repubblica Ceca 28
KE - Kenya 28
AE - Emirati Arabi Uniti 26
CO - Colombia 25
EG - Egitto 25
NP - Nepal 23
SA - Arabia Saudita 23
CH - Svizzera 21
LB - Libano 21
LT - Lituania 21
PY - Paraguay 21
AZ - Azerbaigian 18
IL - Israele 18
KZ - Kazakistan 18
DZ - Algeria 17
TW - Taiwan 17
UY - Uruguay 17
JM - Giamaica 16
BG - Bulgaria 13
GR - Grecia 13
JO - Giordania 13
PE - Perù 13
CR - Costa Rica 12
PT - Portogallo 12
EU - Europa 11
OM - Oman 11
TH - Thailandia 11
BO - Bolivia 10
DO - Repubblica Dominicana 10
PA - Panama 10
AL - Albania 9
DK - Danimarca 9
KG - Kirghizistan 9
GE - Georgia 8
TT - Trinidad e Tobago 8
HU - Ungheria 7
BY - Bielorussia 6
HN - Honduras 6
MD - Moldavia 6
MM - Myanmar 6
PS - Palestinian Territory 6
UG - Uganda 6
EE - Estonia 5
NG - Nigeria 5
RS - Serbia 5
SY - Repubblica araba siriana 5
AM - Armenia 4
CY - Cipro 4
ET - Etiopia 4
GA - Gabon 4
LV - Lettonia 4
QA - Qatar 4
SN - Senegal 4
AO - Angola 3
LY - Libia 3
MK - Macedonia 3
Totale 48.477
Salva come PNG Salva come JPEG
Città #
Ashburn 3.042
Singapore 2.481
Fairfield 2.429
Chandler 1.375
Woodbridge 1.347
Houston 1.136
Wilmington 1.097
San Jose 1.058
Ann Arbor 1.035
Hong Kong 985
Seattle 963
Cambridge 788
Moscow 633
Palermo 610
Zgierz 489
Beijing 407
Council Bluffs 397
Dublin 378
Los Angeles 377
Jacksonville 374
New York 372
The Dalles 367
Tokyo 345
Helsinki 339
Santa Clara 336
Medford 332
Dallas 327
Ho Chi Minh City 295
Frankfurt am Main 278
Des Moines 258
Nanjing 252
Lauterbourg 235
Hefei 218
Hanoi 213
Princeton 213
Altamura 205
Rome 177
Lawrence 174
San Diego 164
Munich 155
São Paulo 141
Boardman 132
Chicago 132
Brussels 123
Buffalo 122
Dearborn 120
Tulsa 111
Milan 107
London 106
Ludwigshafen am Rhein 104
Orem 100
Phoenix 87
Jinan 83
Seoul 83
Shenyang 80
Warsaw 75
Nuremberg 72
Seongnam 70
Tianjin 68
Nanchang 65
Atlanta 61
Kitzingen 61
Venice 61
Hebei 60
Guangzhou 59
Changsha 58
Bremen 55
Kumar 55
Brooklyn 53
Denver 53
Amsterdam 51
Chennai 50
Abidjan 48
Montreal 47
Columbus 46
Poplar 46
Jiaxing 44
Johannesburg 44
Stockholm 42
Baghdad 40
Da Nang 39
Rio de Janeiro 38
Tehran 38
Toronto 38
Ningbo 36
Falls Church 35
Boston 34
Izmir 34
Saint Petersburg 34
San Mateo 34
Haiphong 33
Verona 33
Hangzhou 32
Panama City 32
Shanghai 32
San Paolo di Civitate 31
Auburn Hills 30
Lappeenranta 29
Mumbai 29
Zhengzhou 29
Totale 30.341
Salva come PNG Salva come JPEG
Nome #
4843delC of the BRCA1 gene is a possible founder mutation in Southern Italy (Sicily). 400
The TP53 colorectal cancer international collaborative study on the prognostic and predictive significance of p53 mutation: influence of tumor site, type of mutation, and adjuvant treatment 364
Aurora-A overexpression as an early marker of reflux-related columnar mucosa and Barrett's oesophagus. 361
Analysis of tissue and circulating microRNA expression during metaplastic transformation of the esophagus 349
PD-L1 expression as predictive biomarker in patients with NSCLC: A pooled analysis 341
EGFR inhibition in NSCLC: New findings…. and opened questions? 336
Detection and quantification of mammaglobin in the blood of breast cancer patients: can it be useful as a potential clinical marker? Preliminary results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 333
Dietary restriction: could it be considered as speed bump on tumor progression road? 322
Denosumab for bone health in prostate and breast cancer patients receiving endocrine therapy? A systematic review and a meta-analysis of randomized trials 321
Analysis of molecular mechanisms and anti-tumoural effects of zoledronic acid in breast cancer cells 319
Analysis of miRNA expression profile induced by short term starvation in breast cancer cells treated with doxorubicin 318
Aberrant methylation within RUNX3 CpG island associated with the nuclear and mitochondrial microsatellite instability in sporadic gastric cancers. Results of a GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 317
Clinical Potential of Circulating Cell-Free DNA (cfDNA) for Longitudinally Monitoring Clinical Outcomes in the First-Line Setting of Non-Small-Cell Lung Cancer (NSCLC): A Real-World Prospective Study 316
Absence of germline CDKN2A mutation in Sicilian Patients with Familial Malignant Melanoma: could it be a population-specific genetic signature? 314
Stabilizing versus destabilizing the microtubules: A double-edge sword for an effective cancer treatment option? 310
Analysis of Germline Gene Copy Number Variants of Patients with Sporadic Pancreatic Adenocarcinoma Reveals Specific Variations 305
Male breast cancer. 302
TP53 and p16INK4A, but not H-KI-Ras, are involved in tumorigenesis and progression of pleomorphic adenomas. 301
Genetic and molecular characterization of the human osteosarcoma 3AB-OS cancer stem cell line: a possible model for studying osteosarcoma origin and stemness. 300
"Back to a false normality": New intriguing mechanisms of resistance to PARP inhibitors 299
Significance of P16INK4A hypermethylation gene in primary head/neck and colorectal tumors: it is a specific tissue event? Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 297
Anti-endothelin drugs in solid tumors 296
Founder mutations in BRCA1 and BRCA2 genes 295
EGF Induces STAT3-Dependent VEGF Expression in HT-29 colon cancer cells 289
Analysis of Ki-Ras mutations in stage I rectal carcinomas and respective regional lymph nodes. 288
EFFECT OF miR-21, miR-182 AND let-7i ON TSP-1 EXPRESSION IN COLON CANCER CELL LINE 288
Analysis of germline gene copy number variants of patients with sporadic pancreatic adenocarcinoma reveals specific variations 286
A new germline mutation in BRCA1 gene in a sicilian family with ovarian cancer. 281
A headlight on liquid biopsies: a challenging tool for breast cancer management 280
Can the microRNA expression profile help to identify novel targets for zoledronic acid in breast cancer? 279
What are the Cancer Risks in BRCA Carriers Apart from Those Regarding the Breast and the Ovary? 279
BRCA1 genetic testing in 106 breast and ovarian cancer families from southern Italy (Sicily): a mutation analyses. 276
Breast cancer genome-wide association studies: there is strength in numbers 276
Monitoring blood biomarkers to predict nivolumab effectiveness in NSCLC patients 271
I tumori della mammella e/o dell’ovaio di tipo eredofamiliare: strategie di prevenzione nelle donne ad alto rischio 270
One shot NEPA plus dexamethasone to prevent multiple-day chemotherapy in sarcoma patients 270
BRCA1 and BRCA2 germline mutations in sicilian breast and/or ovarian cancer families and their association with familial profiles 267
How to Deal with Second Line Dilemma in Metastatic Colorectal Cancer? A Systematic Review and Meta-Analysis 266
BRCA1/BRCA2 genes mutational screening in Sicilian breast and/or ovarian cancer families. 265
Gastric adenomas: relationship between clinicopathological findings, Helicobacter pylori infection, APC mutations and COX-2 expression. 265
BRCA1 and BRCA2 variants of uncertain clinical significance and their implications for genetic counseling 263
How Much of Familial Breast Cancer Risk is Currently Explained by the Known Genes? 263
Effects of anti-miR-182 on TSP-1 expression in human colon cancer cells: there is a sense in antisense? 262
BRCA 1/2 GENES MUTATIONAL SCREENING IN SICILIAN BREAST AND/OR OVARIAN CANCER FAMILIES 261
Triple negative breast cancer: Shedding light onto the role of pi3k/akt/mtor pathway 261
TP53 mutations and S-phase fraction but not DNA-ploidy are independent prognostic indicators in laryngeal squamous cell carcinoma 259
HepatomiRNoma: The proposal of a new network of targets for diagnosis, prognosis and therapy in hepatocellular carcinoma 257
Apoptosis: a relevant tool for anticancer therapy. 256
Specific TP53 and/or Ki-ras mutations as independent predictors of clinical outcome in sporadic colorectal adenocarcinomas: results of a 5-year Gruppo Oncologico dell'Italia Meridionale (GOIM) prospective study. 253
The role of microRNAs in cancer: diagnostic and prognostic biomarkers and targets of therapies 253
What links BRAF to the heart function? New insights from the cardiotoxicity of BRAF inhibitors in cancer treatment 253
Heterogeneity within and between primary colorectal carcinomas and matched metastases as revealed by analysis of Ki-ras and p53 mutations 253
Ductal lavage: a valid method of risk assessment and of early diagnosis in breast cancer. 252
Molecular detection of TP53, Ki-Ras and p16INK4A promoter methylation in plasma of patients with colorectal cancer and its association with prognosis. Results of a 3-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study. 252
Nintedanib in NSCLC: Evidence to date and place in therapy 252
Ductal lavage: a way of carefully tracing the breast-secreting duct 251
Q356R and S1512I are BRCA1 variants that may be associated with breast cancer in a Sicilian family. 250
Metastatic site location influences the diagnostic accuracy of ctDNA EGFR- mutation testing in NSCLC patients: a pooled analysis 250
Effects of PPARγ agonists on the expression of leptin and vascular endothelial growth factor in breast cancer cells. 250
New findings on primary and acquired resistance to anti-EGFR therapy in metastatic colorectal cancer: Do all roads lead to RAS? 249
Prognostic and predictive factors in colorectal cancer: Kirsten Ras in CRC (RASCAL) and TP53CRC collaborative studies. 248
BRCA1 germline mutations in Sicilian breast and/or ovarian cancer families and their implications for genetic counselling. 248
HIF-1 is involved in the negative regulation of AURKA expression in breast cancer cell lines under hypoxic conditions 247
Havep53 gene mutations and protein expression a different biological significance in colorectal cancer? 247
The role of Aurora-A inhibitors in cancer therapy. 246
Molecular analysis of TP53, Ki-Ras and P16 methylation status in tissue and plasma of subjects affected by gastrointestinal cancer (GIC) 246
Analysis of TP53, Ki-Ras and P16INK4A promoter methylation as potential prognostic factors in patients with colorectal cancer 245
Laser Pressure Catapulting (LPC): Optimization LPC-System and Genotyping of Colorectal Carcinomas 243
Monoclonal antibodies in gastrointestinal cancers 243
Farletuzumab for NSCLC: Exploiting a well-known metabolic pathway for a new therapeutic strategy 241
Analysis of systemic inflammatory biomarkers in neuroendocrine carcinomas of the lung: prognostic and predictive significance of NLR, LDH, ALI, and LIPI score 240
Patterns of K-ras mutation in colorectal carcinomas from Iran and Italy (a Gruppo Oncologico dell'Italia Meridionale study): influence of microsatellite instability status and country of origin. 239
VUS variants in BRCA genes of hereditary breast/ovarian cancer 237
Aplotype analysis in four sicilian families with 5083del19bp-BRCA1. 237
A missense mutation associated to early onset breast cancer in a sicilian woman. 236
Y179C, F486L and N550H are BRCA1 variants that may be associated with breast cancer in a Sicilian family: results of a 5-year GOIM (Gruppo Oncologico dell'Italia Meridionale) prospective study 236
MicroRNAs in colorectal cancer stem cells: new regulators of cancer stemness? 236
miR-20b Modulates VEGF Expression by Targeting HIF-1a and STAT3 in MCF-7 Breast Cancer Cells 234
MicroRNAs in Colorectal Cancer Drug Resistance: Shooters become Targets 233
Beyond evidence-based data: Scientific rationale and tumor behavior to drive sequential and personalized therapeutic strategies for the treatment of metastatic renal cell carcinoma 233
Genotype analysis of colorectal carcinomas through laser pressare catapulting (LPC) 232
Hypoxia and Human Genome Stability: Downregulation of BRCA2 Expression in Breast Cancer Cell Lines 232
High prevalence of BRCA1 deletions in BRCAPRO-positive patients with high carrier probability. 231
TP53, Ki-Ras and P16INK4A gene molecular analysis in salivary gland tumors. 230
Downregulated expression of Cdc25A gene in MCF-7 breast cancer cell 229
TP53 mutations and microsatellite instability are prognostic factors in gastric cancer? 228
Pharmacogenomics in colorectal carcinomas: Future perspectives in personalized therapy 227
A study of a new germline mutation in BRCA1 gene in two Sicilian families: a founder mutation? 227
P16 ink4A, p53 alterations and S phase fraction are predictive of clinical outcome in laryngeal squamous cell carcinoma. 226
Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study. 226
Monoclonal antibodies and antibody fragments: state of the art and future perspectives in the treatment of non-haematological tumors 226
BRCA1/2 pathogenic variants in triple-negative versus luminal-like breast cancers: genotype–phenotype correlation in a cohort of 531 patients 225
Conquests and perspectives of cardio-oncology in the field of tumor angiogenesis-targeting tyrosine kinase inhibitor-based therapy 225
GENOTYPE ANALYSIS OF COLORECTAL CARCINOMAS THROUGH LASER PRESSURE CATAPULTING (LPC) 224
Non-Small Cell Lung Cancer Harboring Concurrent EGFR Genomic Alterations: A Systematic Review and Critical Appraisal of the Double Dilemma 221
CALR MUTATIONS IN SICILIAN ESSENTIAL THROMBOCYTHEMIA AND MYELOFIBROSIS PATIENTS. 218
Detection of RAS mutations in circulating tumor DNA: a new weapon in an old war against colorectal cancer. A systematic review of literature and meta-analysis 218
Role of K-RAS and P53 Gene in Salivary Glands Tumorigenesis 217
Hereditary ovarian cancer 217
Potential Role of ANGPTL4 in the Cross Talk between Metabolism and Cancer through PPAR Signaling Pathway 217
Totale 26.523
Salva come PNG Salva come JPEG
Categoria #
all - tutte 159.488
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 159.488
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021683 0 0 0 0 0 0 0 0 0 0 361 322
2021/20223.094 215 678 84 126 157 121 200 144 287 372 257 453
2022/20233.910 426 749 86 468 429 583 216 283 410 30 171 59
2023/20242.018 84 241 139 157 127 405 230 241 21 71 23 279
2024/20255.922 103 356 383 434 261 294 622 559 357 733 753 1.067
2025/202618.584 1.645 625 1.222 1.575 1.902 2.886 2.541 1.947 1.399 2.369 473 0
Totale 49.762